Johnson Bryan A, Xie Xuping, Kalveram Birte, Lokugamage Kumari G, Muruato Antonio, Zou Jing, Zhang Xianwen, Juelich Terry, Smith Jennifer K, Zhang Lihong, Bopp Nathen, Schindewolf Craig, Vu Michelle, Vanderheiden Abigail, Swetnam Daniele, Plante Jessica A, Aguilar Patricia, Plante Kenneth S, Lee Benhur, Weaver Scott C, Suthar Mehul S, Routh Andrew L, Ren Ping, Ku Zhiqiang, An Zhiqiang, Debbink Kari, Shi Pei Yong, Freiberg Alexander N, Menachery Vineet D
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
bioRxiv. 2020 Aug 26:2020.08.26.268854. doi: 10.1101/2020.08.26.268854.
SARS-CoV-2 has resulted in a global pandemic and shutdown economies around the world. Sequence analysis indicates that the novel coronavirus (CoV) has an insertion of a furin cleavage site (PRRAR) in its spike protein. Absent in other group 2B CoVs, the insertion may be a key factor in the replication and virulence of SARS-CoV-2. To explore this question, we generated a SARS-CoV-2 mutant lacking the furin cleavage site (ΔPRRA) in the spike protein. This mutant virus replicated with faster kinetics and improved fitness in Vero E6 cells. The mutant virus also had reduced spike protein processing as compared to wild-type SARS-CoV-2. In contrast, the ΔPRRA had reduced replication in Calu3 cells, a human respiratory cell line, and had attenuated disease in a hamster pathogenesis model. Despite the reduced disease, the ΔPRRA mutant offered robust protection from SARS-CoV-2 rechallenge. Importantly, plaque reduction neutralization tests (PRNT ) with COVID-19 patient sera and monoclonal antibodies against the receptor-binding domain found a shift, with the mutant virus resulting in consistently reduced PRNT titers. Together, these results demonstrate a critical role for the furin cleavage site insertion in SARS-CoV-2 replication and pathogenesis. In addition, these findings illustrate the importance of this insertion in evaluating neutralization and other downstream SARS-CoV-2 assays.
As COVID-19 has impacted the world, understanding how SARS-CoV-2 replicates and causes virulence offers potential pathways to disrupt its disease. By removing the furin cleavage site, we demonstrate the importance of this insertion to SARS-CoV-2 replication and pathogenesis. In addition, the findings with Vero cells indicate the likelihood of cell culture adaptations in virus stocks that can influence reagent generation and interpretation of a wide range of data including neutralization and drug efficacy. Overall, our work highlights the importance of this key motif in SARS-CoV-2 infection and pathogenesis.
A deletion of the furin cleavage site in SARS-CoV-2 amplifies replication in Vero cells, but attenuates replication in respiratory cells and pathogenesis in vivo. Loss of the furin site also reduces susceptibility to neutralization .
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)已导致全球大流行并使世界各地的经济停摆。序列分析表明,这种新型冠状病毒(CoV)的刺突蛋白中有一个弗林蛋白酶切割位点(PRRAR)插入。在其他2B组冠状病毒中不存在这种插入,它可能是SARS-CoV-2复制和毒力的关键因素。为探究这个问题,我们构建了一种SARS-CoV-2突变体,其刺突蛋白中缺失弗林蛋白酶切割位点(ΔPRRA)。这种突变病毒在Vero E6细胞中以更快的动力学进行复制且适应性增强。与野生型SARS-CoV-2相比,该突变病毒的刺突蛋白加工也减少。相反,ΔPRRA在人呼吸道细胞系Calu3细胞中的复制减少,并且在仓鼠发病模型中的致病力减弱。尽管致病力降低,但ΔPRRA突变体对SARS-CoV-2再次攻击提供了强大的保护。重要的是,用COVID-19患者血清和针对受体结合域的单克隆抗体进行的空斑减少中和试验(PRNT)发现了一种变化,突变病毒导致PRNT滴度持续降低。总之,这些结果证明了弗林蛋白酶切割位点插入在SARS-CoV-2复制和发病机制中的关键作用。此外,这些发现说明了这种插入在评估中和及其他下游SARS-CoV-2检测中的重要性。
由于COVID-19对全球产生了影响,了解SARS-CoV-2如何复制并导致毒力可为阻断其致病过程提供潜在途径。通过去除弗林蛋白酶切割位点,我们证明了这种插入对SARS-CoV-2复制和发病机制的重要性。此外,在Vero细胞中的研究结果表明病毒株在细胞培养中可能发生适应性变化,这会影响试剂的产生以及包括中和和药物疗效在内的广泛数据的解读。总体而言,我们的工作突出了这一关键基序在SARS-CoV-2感染和发病机制中的重要性。
SARS-CoV-2中弗林蛋白酶切割位点的缺失增强了其在Vero细胞中的复制,但减弱了其在呼吸道细胞中的复制及体内致病力。弗林蛋白酶切割位点的缺失还降低了其对中和作用的敏感性。